Literature DB >> 6602325

Is there an increased risk of Haemophilus influenzae septicemia in children with sickle cell anemia?

D Powars, G Overturf, E Turner.   

Abstract

The risk of Haemophilus influenzae septicemia/meningitis to children who have sickle cell anemia (SS) has been determined to be greater than that seen among normal infants. Of ten bacteriologically proven cases, eight episodes of infection were observed among 234 children with sickle cell anemia (645 person-years), who were less than 5 years of age. There was one case per 69 infants with sickle cell anemia who were less than 18 months old and one case per 36 children with sickle cell anemia between 19 and 59 months of age. Unexpectedly, two infections occurred among 224 children (824 person-years), aged 5 to 9 years; both died. Contrary to the rapid clinical course of pneumococcal infections in children with sickle cell anemia H influenzae septicemia was regularly heralded by a greater than 24-hour prodrome of upper respiratory tract infection, low-grade fever, and otitis media. Three (30%) preventable deaths occurred. Antibiotic therapy for the febrile child with sickle cell anemia must be predicated on the known 400-fold increased risk of pneumococcal septicemia in those less than 5 years old and the fourfold risk of H influenzae septicemia in those less than 9 years of age.

Entities:  

Mesh:

Year:  1983        PMID: 6602325

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Recurrent infections in homozygous sickle cell disease.

Authors:  S A Magnus; I R Hambleton; F Moosdeen; G R Serjeant
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

2.  Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.

Authors:  Slimane Allali; Martin Chalumeau; Odile Launay; Samir K Ballas; Mariane de Montalembert
Journal:  Cochrane Database Syst Rev       Date:  2018-08-20

3.  Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease.

Authors:  D Goldblatt; M Johnson; J Evans
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

4.  Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease.

Authors:  Marianne E Yee; Nitya Bakshi; Sara H Graciaa; Peter A Lane; Robert C Jerris; Yun F Wang; Inci Yildirim
Journal:  Pediatr Blood Cancer       Date:  2019-02-05       Impact factor: 3.167

5.  Improved survival in homozygous sickle cell disease: lessons from a cohort study.

Authors:  A Lee; P Thomas; L Cupidore; B Serjeant; G Serjeant
Journal:  BMJ       Date:  1995-12-16

6.  Anticapsular antibody requirements for protection against experimental Haemophilus influenzae type b bacteremia after splenectomy.

Authors:  L G Rubin
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

Review 7.  Sickle Cell Disease in Sub-Saharan Africa.

Authors:  Thomas N Williams
Journal:  Hematol Oncol Clin North Am       Date:  2016-01-28       Impact factor: 3.722

Review 8.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Sarah J Nevitt; Ashley P Jones; Jo Howard
Journal:  Cochrane Database Syst Rev       Date:  2017-04-20

9.  Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study.

Authors:  Thomas N Williams; Sophie Uyoga; Alex Macharia; Carolyne Ndila; Charlotte F McAuley; Daniel H Opi; Salim Mwarumba; Julie Makani; Albert Komba; Moses N Ndiritu; Shahnaaz K Sharif; Kevin Marsh; James A Berkley; J Anthony G Scott
Journal:  Lancet       Date:  2009-09-09       Impact factor: 79.321

Review 10.  Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use.

Authors:  M P E Slack; A W Cripps; K Grimwood; G A Mackenzie; M Ulanova
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.